125 related articles for article (PubMed ID: 1549692)
1. Compositional changes in vertebral bone marrow during treatment for acute leukemia: assessment with quantitative chemical shift imaging.
Gerard EL; Ferry JA; Amrein PC; Harmon DC; McKinstry RC; Hoppel BE; Rosen BR
Radiology; 1992 Apr; 183(1):39-46. PubMed ID: 1549692
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of the bone marrow in patients with acute leukemia during and after chemotherapy. Changes in T1 relaxation.
Jensen KE; Grundtvig Sørensen P; Thomsen C; Christoffersen P; Henriksen O; Karle H
Acta Radiol; 1990 Jul; 31(4):361-9. PubMed ID: 2206692
[TBL] [Abstract][Full Text] [Related]
3. Hematologic bone marrow disorders: quantitative chemical shift MR imaging.
Rosen BR; Fleming DM; Kushner DC; Zaner KS; Buxton RB; Bennet WP; Wismer GL; Brady TJ
Radiology; 1988 Dec; 169(3):799-804. PubMed ID: 3187003
[TBL] [Abstract][Full Text] [Related]
4. [Magnetic resonance imaging (MRI) of bone marrow necrosis].
Takasaki S; Otsuka T; Gondo H; Kamura K; Nomoto M; Kaida M; Shimoda K; Takamatsu Y; Teshima T; Nakamura M
Rinsho Ketsueki; 1994 Dec; 35(12):1349-54. PubMed ID: 7861614
[TBL] [Abstract][Full Text] [Related]
5. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease.
Johnson LA; Hoppel BE; Gerard EL; Miller SP; Doppelt SH; Zirzow GC; Rosenthal DI; Dambrosia JM; Hill SC; Brady RO
Radiology; 1992 Feb; 182(2):451-5. PubMed ID: 1732964
[TBL] [Abstract][Full Text] [Related]
6. Sequential quantitative MR analysis of bone marrow: differences during treatment of lymphoid versus myeloid leukemia.
Vande Berg BC; Michaux L; Scheiff JM; Malghem J; Lecouvet FE; Bourgois MP; Ferrant A; Michaux JL; Maldague BE
Radiology; 1996 Nov; 201(2):519-23. PubMed ID: 8888252
[TBL] [Abstract][Full Text] [Related]
7. Lipid selective MR imaging and localized 1H spectroscopy of bone marrow during therapy of leukemia.
Schick F; Einsele H; Lutz O; Claussen CD
Anticancer Res; 1996; 16(3B):1545-51. PubMed ID: 8694524
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission.
Chen BB; Hsu CY; Yu CW; Hou HA; Liu CY; Wei SY; Chou WC; Tien HF; Shih TT
Radiology; 2011 Mar; 258(3):821-31. PubMed ID: 21212370
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
10. Repopulation of marrow after transplantation: MR imaging with pathologic correlation.
Stevens SK; Moore SG; Amylon MD
Radiology; 1990 Apr; 175(1):213-8. PubMed ID: 2315483
[TBL] [Abstract][Full Text] [Related]
11. [Pathomorphosis of acute leukemia].
Popov VM
Sov Med; 1991; (9):15-8. PubMed ID: 1724709
[TBL] [Abstract][Full Text] [Related]
12. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
13. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
[No Abstract] [Full Text] [Related]
15. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
16. A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia.
Cooper BW; Veal GJ; Radivoyevitch T; Tilby MJ; Meyerson HJ; Lazarus HM; Koc ON; Creger RJ; Pearson G; Nowell GM; Gosky D; Ingalls ST; Hoppel CL; Gerson SL
Clin Cancer Res; 2004 Oct; 10(20):6830-9. PubMed ID: 15501959
[TBL] [Abstract][Full Text] [Related]
17. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia.
Roberts WM; Estrov Z; Ouspenskaia MV; Johnston DA; McClain KL; Zipf TF
N Engl J Med; 1997 Jan; 336(5):317-23. PubMed ID: 9011783
[TBL] [Abstract][Full Text] [Related]
18. [MR relaxation times in diffuse bone marrow disorders: evaluation of their clinical usefulness in differentiation between leukemia and anemia].
Tanaka O; Ichikawa T; Kobayashi Y; Matsuura K; Nagai J; Takagi S
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jul; 56(8):539-45. PubMed ID: 8797343
[TBL] [Abstract][Full Text] [Related]
19. The distribution of the magnetic field in the spine depends on the composition of bone marrow.
Schick F
J Magn Reson B; 1995 Jul; 108(1):1-11. PubMed ID: 7627431
[TBL] [Abstract][Full Text] [Related]
20. Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.
Steinherz PG; Shukla N; Kobos R; Steinherz L
Pediatr Blood Cancer; 2010 May; 54(5):687-93. PubMed ID: 20205253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
